P. Arumugam

发表

Long non-coding RNAs as a therapeutic target for periodontitis

Balachander Kannan, P. Arumugam, B. Kannan, 2022, Journal of dental sciences.

EPIGENETIC MECHANISMS INVOLVED IN PHASE SWITCHING PROCESS EXHIBITED BY CANDIDA ALBICANS.

P. Arumugam, V. Jayaseelan, SmilineGirija A.S, 2016 .

Thymoquinone inhibits the migration of mouse neuroblastoma (Neuro-2a) cells by down-regulating MMP-2 and MMP-9.

J. Priyadharsini, R. Subramanian, P. Arumugam, 2016, Chinese journal of natural medicines.

A Rare Biotinidase Deficiency in the Pediatrics Population: Genotype–Phenotype Analysis

Balachander Kannan, P. Arumugam, V. Jayaseelan, 2022, Journal of Pediatric Genetics.

Prevalence of VIM- and GIM-producing Acinetobacter baumannii from patients with severe urinary tract infection.

S. Girija, P. Arumugam, V. Jayaseelan, 2018, Acta microbiologica et immunologica Hungarica.

Exosomal microRNAs as a promising theragnostic tool for essential hypertension

P. Arumugam, V. Jayaseelan, 2019, Hypertension Research.

Myocilin mutations among POAG patients from two populations of Tamil Nadu, South India, a comparative analysis

K. Muthusamy, A. Balakrishnan, P. Arumugam, 2011, Molecular vision.

Overexpression of BASP1 Indicates a Poor Prognosis in HNSCC

A. Ram, S. As, P. Arumugam, 2020 .

Genetic Alterations in DNMT Genes and Its Putative Association with HNSCC

J. Priyadharsini, S. As, P. Arumugam, 2020 .

Overexpression of BASP1 Indicates a Poor Prognosis in Head and Neck Squamous Cell Carcinoma

A. Ram, S. As, P. Arumugam, 2020, Asian Pacific journal of cancer prevention : APJCP.

A Computational Data Mining Strategy to Identify the Common Genetic Markers of Temporomandibular Joint Disorders and Osteoarthritis

P. Arumugam, V. Jayaseelan, 2022, Global medical genetics.

ASSOCIATION OF PLEKHA7 (rs11024074) AND ULK4 (rs1052501) GENE POLYMORPHISM WITH ESSENTIAL HYPERTENSION RISK AMONG SOUTH INDIAN POPULATION

K. Muthusamy, S. Venkatramani, S. Thiagarajan, 2018 .

Exosomal microRNAs Targeting TP53 Gene as Promising Prognostic Markers for Head and Neck Squamous Cell Carcinoma

P. Arumugam, V. Jayaseelan, 2022, Global Medical Genetics.

Identification of Novel Cytochrome C1 (CYC1) Gene Expression in Oral Squamous Cell Carcinoma- An Evaluative Study

P. Ramani, A. Ramasubramanian, Balachander Kannan, 2022, Annals of maxillofacial surgery.

Aberrations of m6A regulators are associated with tumorigenesis and metastasis in head and neck squamous cell carcinoma.

Rinku K. George, P. Arumugam, V. Jayaseelan, 2020, Archives of oral biology.

Epigenetic Role of Onco-miRs in Oral Squamous Cell Carcinoma: A Clue to Modern Medicine

S. Girija, P. Arumugam, V. Jayaseelan, 2016 .

Gender-specific Association of ATP2B1 (rs2681472) Gene Polymorphism with Essential Hypertension in South Indian Population

K. Muthusamy, S. Venkatramani, S. Thiagarajan, 2017 .

Exosome-derived ncRNAs as potential drivers of epigenetic reprogramming of cancer stem cells.

P. Arumugam, V. Jayaseelan, 2021, Epigenomics.

A Computational Approach to Identify the Mutations in the Genes of the RTK Signaling Pathway and their Possible Association with Oral Squamous Cell Carcinoma

A. Girija, Aditya V Jain, P. Arumugam, 2020 .

Immunotherapy for oral cancer treatment through targeting of IDO1 and its pathway.

Balachander Kannan, P. Arumugam, V. Jayaseelan, 2022, Journal of Stomatology Oral and Maxillofacial Surgery.

Decoding the Genetic Alterations in Genes of DNMT Family (DNA Methyl-Transferase) and their Association with Head and Neck Squamous Cell Carcinoma

J. Priyadharsini, S. As, P. Arumugam, 2020, Asian Pacific journal of cancer prevention : APJCP.

Post-transcriptional gene silencing by nucleic acid gapmers: a promising therapeutic modality for cancer.

J. Priyadharsini, P. Arumugam, 2023, Epigenomics.

Exosome engineering: a promising step toward cancer therapeutics.

P. Arumugam, V. Jayaseelan, 2022, Epigenomics.

Dysregulated m6A methylation modification is associated with human peri-implantitis - A pilot study.

Dhanraj Ganapathy, Balachander Kannan, P. Arumugam, 2023, Journal of stomatology, oral and maxillofacial surgery.

RFC3 serves as a novel prognostic biomarker and target for head and neck squamous cell carcinoma

Balachander Kannan, P. Arumugam, V. Jayaseelan, 2023, Clinical Oral Investigations.

DYNC1I1 acts as a promising prognostic biomarker and is correlated with immune infiltration in head and neck squamous cell carcinoma.

Balachander Kannan, P. Arumugam, V. Jayaseelan, 2023, Journal of stomatology, oral and maxillofacial surgery.

Increased Expression of LIPC Is Associated With the Clinicopathological Features and Development of Head and Neck Squamous Cell Carcinoma

Balachander Kannan, P. Arumugam, Vijayashree J Priyadharsini, 2023, Cureus.

Exploring the Expression of BCAS3 in Head and Neck Squamous Cell Carcinoma and Its Association With Prognosis

Balachander Kannan, P. Arumugam, Vijayashree J Priyadharsini, 2023, Cureus.

Waterpipe smoke condensate induces epithelial-mesenchymal transformation and promotes metastasis of oral cancer by FOXD1 expression.

P. Ramani, A. Ramasubramanian, P. Arumugam, 2024, Journal of stomatology, oral and maxillofacial surgery.

Increased SEC14L2 expression is associated with clinicopathological features and worse prognosis in oral squamous cell carcinoma.

P. Arumugam, V. Jayaseelan, C. Pandi, 2024, Odontology.

Alteration of SERPINH1 is associated with elevated expression in Head and Neck Squamous Cell Carcinomas and its clinicopathological significance.

S. As, P. Arumugam, V. Jayaseelan, 2024, Journal of stomatology, oral and maxillofacial surgery.

Altered expression of GLS2 indicates a poor prognosis and correlates with clinicopathological features of oral squamous cell carcinoma.

P. Arumugam, V. Jayaseelan, C. Pandi, 2024, International journal of oral and maxillofacial surgery.

Aberrated PSMA1 expression associated with clinicopathological features and prognosis in oral squamous cell carcinoma.

P. Arumugam, V. Jayaseelan, Prathibha Prasad, 2024, Odontology.

Alteration in PNMA1 expression is associated with poor prognosis and tumor immune infiltration in head and neck squamous cell carcinoma

P. Arumugam, V. Jayaseelan, B. Kannan, 2023, Journal of oral biology and craniofacial research.

EXT2: a novel prognostic and predictive biomarker for head and neck squamous cell carcinoma.

P. Arumugam, V. Jayaseelan, C. Pandi, 2023, Oral surgery, oral medicine, oral pathology and oral radiology.

Prognostic and clinicopathological significance of MRC2 expression in head and neck squamous cell carcinoma.

P. Arumugam, V. Jayaseelan, C. Pandi, 2023, Journal of stomatology, oral and maxillofacial surgery.

Triggering receptor expressed in myeloid cells 1 (TREM1) as a potential prognostic biomarker and association with immune infiltration in oral squamous cell carcinoma.

P. Arumugam, V. Jayaseelan, C. Pandi, 2024, Archives of oral biology.

High expression of novel biomarker TBRG4 promotes the progression and invasion of oral squamous cell carcinoma.

P. Ramani, A. Ramasubramanian, P. Arumugam, 2023, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.